HDAC1 and HDAC2 have been shown to be crucial for cell proliferation and are therefore considered as promising targets for anti-tumour therapy (Lagger et al, 2002; Haberland et al, 2010; Yamaguchi et al, 2010). Here, HDAC2 is linked to neoplasm.